S-ICD SYSTEM
Report
- Report Number
- 3009448963-2014-00050
- Event Type
- Malfunction
- Date Received
- May 7, 2014
- Date of Event
- June 22, 2012
- Report Date
- April 9, 2014
- Manufacturer
- CAMERON HEALTH INC
- Product Code
- NVY
- PMA / PMN Number
- P11042
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- NZ
- Reporter Occupation
- PHYSICIAN
Narratives
AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.
BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (S-ICD) AND ELECTRODE WERE IMPLANTED WITHOUT ANY COMPLICATIONS. INDUCTION TESTING WAS PERFORMED AND THE SYSTEM SUCCESSFULLY TERMINATED THE INDUCED ARRHYTHMIA. ALL MEASUREMENTS WERE IN NORMAL RANGE. DURING PRE-DISCHARGE TESTING OF THE SYSTEM, AN ARTIFACT WAS OBSERVED ON THE ELECTROGRAM. THE DATA WAS SENT TO BOSTON SCIENTIFIC TECHNICAL SERVICES (TS) WAS FURTHER EVALUATION. THE ENGINEERING TEAM REVIEWED THE ARTIFACT AND DISCUSSED THAT IT WAS POSSIBLY A RESULT OF A RESIDUAL ENERGY FIELD THAT HAD FORMED AROUND THE ELECTRODE COIL AFTER THE SHOCK DELIVERY. THE DEVICE WAS PROGRAMMED TO AN APPROPRIATE SENSING VECTOR WHERE THE ARTIFACT WAS NOT OBSERVED. THERE HAVE BEEN NO FURTHER SENSING ISSUES NOTED SINCE. NO ADVERSE PATIENT EFFECTS WERE REPORTED. THE ELECTRODE AND S-ICD REMAIN IMPLANTED AND IN SERVICE. ADDITIONAL INFORMATION WAS LATER REPORTED THAT THE S-ICD AND ELECTRODE WERE EXPLANTED AS A RESULT OF AN INFECTION. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED. THIS INFECTION INFORMATION IS REFERENCED IN MDR REPORT 3009448963-2013-00080 AND 3009448963-2013-00081. THE ELECTRODE AND S-ICD WERE NOT RETURNED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 276763 | S-ICD SYSTEM | IMPLANTABLE LEAD | NVY | CAMERON HEALTH INC | 3010 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 65 YR | (B)(4) |